These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 31930034)

  • 1. Based on network pharmacology to explore the molecular mechanisms of astragalus membranaceus for treating T2 diabetes mellitus.
    Li J; Huang Y; Zhao S; Guo Q; Zhou J; Han W; Xu Y
    Ann Transl Med; 2019 Nov; 7(22):633. PubMed ID: 31930034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revealing the potential mechanism of Astragalus membranaceus improving prognosis of hepatocellular carcinoma by combining transcriptomics and network pharmacology.
    Liu Z; Ma H; Lai Z
    BMC Complement Med Ther; 2021 Oct; 21(1):263. PubMed ID: 34663301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematically investigate the mechanism underlying the therapeutic effect of Astragalus membranaceus in ulcerative colitis.
    Mao J; Tan L; Tian C; Wang W; Zou Y; Zhu Z; Li Y
    Am J Med Sci; 2024 Jul; ():. PubMed ID: 39009282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Network Pharmacology Prediction and Molecular Docking-Based Strategy to Explore the Potential Pharmacological Mechanism of
    Feng Y; Zhu P; Wu D; Deng W
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
    Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
    J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilising Network Pharmacology to Explore Underlying Mechanism of
    Yu H; Ling Q; Cai J; Zhang M; Liu H; Chen Y
    Evid Based Complement Alternat Med; 2022; 2022():7141767. PubMed ID: 35399630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The modulatory properties of
    Zhang Q; Huang X
    PeerJ; 2021; 9():e11995. PubMed ID: 34513331
    [No Abstract]   [Full Text] [Related]  

  • 8. Network Pharmacology and Molecular Docking Analysis on Pharmacological Mechanisms of
    Zhou P; Zhou R; Min Y; An LP; Wang F; Du QY
    Evid Based Complement Alternat Med; 2022; 2022():9007396. PubMed ID: 35140802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Network Pharmacology to Explore the Mechanism of
    Jin Q; Hao XF; Xie LK; Xu J; Sun M; Yuan H; Wang SH; Wu GP; Miao ML
    Evid Based Complement Alternat Med; 2020; 2020():8878569. PubMed ID: 33204295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chinese herb couple against diabetes: integrating network pharmacology and mechanism study.
    Li J; Jia N; Cui M; Li Y; Jiang D; Chu X
    J Biomol Struct Dyn; 2024 Feb; ():1-17. PubMed ID: 38345075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elucidation of the Mechanisms and Molecular Targets of
    Xu M; Li Z; Yang L; Zhai W; Wei N; Zhang Q; Chao B; Huang S; Cui H
    Biomed Res Int; 2020; 2020():5848497. PubMed ID: 32851081
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanism of
    Wang L; Zheng W; Yang J; Ali A; Qin H
    Nutrients; 2022 Feb; 14(5):. PubMed ID: 35267929
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanism exploration of Gouqi-wentang formula against type 2 diabetes mellitus by phytochemistry and network pharmacology-based analysis and biological validation.
    Han L; Yang HY; Zheng YJ; Wei XX; Dan WC; Zhang LL; Ding QY; Ma X; Wang XM; Zhao LH; Tong XL
    Chin Med; 2021 Sep; 16(1):93. PubMed ID: 34579756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network pharmacology-based investigation of potential targets of astragalus membranaceous-angelica sinensis compound acting on diabetic nephropathy.
    Dong Y; Zhao Q; Wang Y
    Sci Rep; 2021 Sep; 11(1):19496. PubMed ID: 34593896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Modulatory Properties of
    Liu C; Wang K; Zhuang J; Gao C; Li H; Liu L; Feng F; Zhou C; Yao K; Deng L; Wang L; Li J; Sun C
    Front Pharmacol; 2019; 10():1171. PubMed ID: 31680955
    [No Abstract]   [Full Text] [Related]  

  • 16. Systematic Evaluation of the Mechanisms of Mulberry Leaf (Morus alba Linne) Acting on Diabetes Based on Network Pharmacology and Molecular Docking.
    Wu Q; Hu Y
    Comb Chem High Throughput Screen; 2021; 24(5):668-682. PubMed ID: 32928080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Aging Implications of
    Liu P; Zhao H; Luo Y
    Aging Dis; 2017 Dec; 8(6):868-886. PubMed ID: 29344421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astragalus membranaceus: A Review of its Protection Against Inflammation and Gastrointestinal Cancers.
    Auyeung KK; Han QB; Ko JK
    Am J Chin Med; 2016; 44(1):1-22. PubMed ID: 26916911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systems pharmacology-based drug discovery and active mechanism of phlorotannins for type 2 diabetes mellitus by integrating network pharmacology and experimental evaluation.
    Chen J; Li P; Ye S; Li W; Li M; Ding Y
    J Food Biochem; 2022 Dec; 46(12):e14492. PubMed ID: 36385377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the Lipid-Lowering Activity and Mechanism of Three Extracts from
    Yang X; Jia M; Luo J; An Y; Chen Z; Bao Y
    Foods; 2024 Sep; 13(17):. PubMed ID: 39272560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.